Discover 222 paid clinical trials in Albany, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 222
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Albany NY, New York NY, Providence RI, Scarborough ME,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Albany NY, Springfield MA, Hartford CT, New Britain CT,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment
for
Quality of Life, Health Care Utilization
Location: Albany NY
Sponsor: Center for Disability Services, New York
Sex: All
Age: 5 - 65
Code: NCT05862662
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Albany NY, Clifton Park NY, Nyack NY, Montreal,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Albany NY, The Bronx NY, East Brunswick NJ,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Albany NY, New Haven CT, Stony Brook NY, New York NY,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Albany NY, New Haven CT, Lebanon NH, Paramus NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Albany NY, White Plains NY, Norwich CT,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
for
Early Breast Cancer
Location: Albany NY, Norwich CT, New Brunswick NJ,
Sponsor: Genentech, Inc.
Sex: Female
Age: 18+
Code: NCT07541079
Phase 3, Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Albany NY, White Plains NY, Rockville MD, Fairfax VA,
Sponsor: BioNTech SE
Sex: Male
Age: 18+
Code: NCT07365995
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer